BC
XBI icon

Brookfield Corp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Brookfield Corp’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-39,500
Closed -$2.93M – 787
2022
Q2 		$2.93M Buy
+39,500
New +$2.97M 0.01% 340

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Brookfield Corp's XBI Position: Q3 2022 in Review

Brookfield Corp sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 39,500 shares — an estimated $2.93M sold.

Brookfield Corp first reported a position in XBI in Q2 2022 and held it in 1 quarter. The position peaked at $2.93M in Q2 2022. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

  • Brookfield Corp reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
  • Brookfield Corp sold 39,500 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $2.93M.
  • Brookfield Corp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 1 quarter.
  • Brookfield Corp's State Street SPDR S&P Biotech ETF position peaked at $2.93M in Q2 2022.
  • 703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Brookfield Corp's 13F filing for Q3 2022, filed 14 Nov 2022.